These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 11821637)

  • 21. Effects of a perindopril-based blood pressure-lowering regimen on the risk of recurrent stroke according to stroke subtype and medical history: the PROGRESS Trial.
    Chapman N; Huxley R; Anderson C; Bousser MG; Chalmers J; Colman S; Davis S; Donnan G; MacMahon S; Neal B; Warlow C; Woodward M;
    Stroke; 2004 Jan; 35(1):116-21. PubMed ID: 14671247
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Blood pressure control and prevention of stroke.
    Karthikeyan VJ; Lip GY
    Expert Rev Neurother; 2006 Feb; 6(2):203-12. PubMed ID: 16466300
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of blood pressure-lowering treatment. 6. Prevention of heart failure and new-onset heart failure--meta-analyses of randomized trials.
    Thomopoulos C; Parati G; Zanchetti A
    J Hypertens; 2016 Mar; 34(3):373-84; discussion 384. PubMed ID: 26780184
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Telmisartan and stroke reduction in the ONTARGET trial: benefit beyond blood pressure lowering?
    Serebruany VL; Atar D; Hanley DF
    Cerebrovasc Dis; 2008; 26(5):563-4. PubMed ID: 18936537
    [No Abstract]   [Full Text] [Related]  

  • 25. Blood pressure-lowering drugs and secondary prevention of cardiovascular disease: systematic review and meta-analysis.
    Xie W; Zheng F; Evangelou E; Liu O; Yang Z; Chan Q; Elliott P; Wu Y
    J Hypertens; 2018 Jun; 36(6):1256-1265. PubMed ID: 29543625
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Benefits and risks of combination therapy in hypertension.
    Node K
    Hypertens Res; 2009 Sep; 32(9):727-8. PubMed ID: 19609269
    [No Abstract]   [Full Text] [Related]  

  • 27. [Need of tight blood pressure control in type 2 diabetes. The intervention study ADVANCE gives clear information].
    Nilsson PM
    Lakartidningen; 2007 Oct 17-23; 104(42):3028-9. PubMed ID: 17985709
    [No Abstract]   [Full Text] [Related]  

  • 28. STOP-Hypertension-2 and best practice for the future.
    Hannson L
    Heart; 2000 Sep; 84 Suppl 1(Suppl 1):i2-4:discussion i50. PubMed ID: 10956309
    [No Abstract]   [Full Text] [Related]  

  • 29. Effects of angiotensin-converting enzyme inhibitors on central blood pressure.
    O'Rourke MF; Nichols WW; Safar ME
    Hypertension; 2007 Sep; 50(3):e63; author reply e64. PubMed ID: 17635848
    [No Abstract]   [Full Text] [Related]  

  • 30. Which drug for treatment of hypertension?
    Cutler J
    Lancet; 1999 Feb; 353(9153):604-5. PubMed ID: 10030320
    [No Abstract]   [Full Text] [Related]  

  • 31. Cerebroprotection mediated by angiotensin II: a hypothesis supported by recent randomized clinical trials.
    Fournier A; Messerli FH; Achard JM; Fernandez L
    J Am Coll Cardiol; 2004 Apr; 43(8):1343-7. PubMed ID: 15093864
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential effects of angiotensin converting enzyme inhibition and diuretic therapy on reductions in ambulatory blood pressure, left ventricular mass, and vascular hypertrophy.
    Roman MJ; Alderman MH; Pickering TG; Pini R; Keating JO; Sealey JE; Devereux RB
    Am J Hypertens; 1998 Apr; 11(4 Pt 1):387-96. PubMed ID: 9607375
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack.
    PROGRESS Collaborative Group
    Lancet; 2001 Sep; 358(9287):1033-41. PubMed ID: 11589932
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on prevention of stroke: Which one is better?
    Xiao L; Ouyang H; Su Q; Huang Y
    Int J Cardiol; 2016 Nov; 223():56-57. PubMed ID: 27532235
    [No Abstract]   [Full Text] [Related]  

  • 35. Effects of a perindopril-based blood pressure-lowering regimen on disability and dependency in 6105 patients with cerebrovascular disease: a randomized controlled trial.
    Fransen M; Anderson C; Chalmers J; Chapman N; Davis S; MacMahon S; Neal B; Sega R; Terent A; Tzourio C; Woodward M;
    Stroke; 2003 Oct; 34(10):2333-8. PubMed ID: 12958329
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PROGRESS - Perindopril Protection Against Recurrent Stroke Study: characteristics of the study population at baseline. Progress Management Committee.
    J Hypertens; 1999 Nov; 17(11):1647-55. PubMed ID: 10608480
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease.
    Tzourio C; Anderson C; Chapman N; Woodward M; Neal B; MacMahon S; Chalmers J;
    Arch Intern Med; 2003 May; 163(9):1069-75. PubMed ID: 12742805
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effects of calcium channel blockers in the prevention of stroke in adults with hypertension: a meta-analysis of data from 273,543 participants in 31 randomized controlled trials.
    Chen GJ; Yang MS
    PLoS One; 2013; 8(3):e57854. PubMed ID: 23483932
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Secondary prevention of stroke with effective antihypertensive treatment].
    Boye Knudsen S; Strandgaard S; Paulson OB
    Ugeskr Laeger; 2013 Apr; 175(15):1024-8. PubMed ID: 23582123
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Reduced risk of stroke recurrence due to hypotensive medication, irrespective of the initial blood pressure].
    Lenders JW; Thien T
    Ned Tijdschr Geneeskd; 2002 Mar; 146(9):398-9. PubMed ID: 11901939
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.